Ginkgo Bioworks Holdings (MEX:DNA) Other Current Liabilities: MXN0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DNA Ginkgo Bioworks Holdings Inc MEX:DNA
54 GF Score
Price MXN170.00
GF Value MXN149.41
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings Other Current Liabilities?

Ginkgo Bioworks Holdings MEX:DNA 54 Other Current Liabilities is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:DNA with a GF Score™ of 54/100 and a GF Value™ of MXN149.41 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Ginkgo Bioworks Holdings's other current liabilities for the quarter that ended in Mar. 2026 was MXN0 Mil.

Ginkgo Bioworks Holdings's quarterly other current liabilities increased from Sep. 2025 (MXN0 Mil) to Dec. 2025 (MXN578 Mil) but then declined from Dec. 2025 (MXN578 Mil) to Mar. 2026 (MXN0 Mil).

Ginkgo Bioworks Holdings's annual other current liabilities declined from Dec. 2023 (MXN923 Mil) to Dec. 2024 (MXN555 Mil) but then increased from Dec. 2024 (MXN555 Mil) to Dec. 2025 (MXN578 Mil).

Ginkgo Bioworks Holdings Other Current Liabilities Related Terms

Ginkgo Bioworks Holdings Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Ginkgo Bioworks Holdings's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ginkgo Bioworks Holdings Other Current Liabilities Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 827.00 1,023.64 923.08 555.20 578.38

Ginkgo Bioworks Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 578.38 0.00
MEX:DNA
54GF Score
Ginkgo Bioworks Holdings Inc MEX:DNA
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ginkgo Bioworks Holdings Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of MXN0 Mil mean?
Ginkgo Bioworks Holdings (MEX:DNA) has a Other Current Liabilities of MXN0 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ginkgo Bioworks Holdings.
Is Ginkgo Bioworks Holdings' Other Current Liabilities too high?
Ginkgo Bioworks Holdings' current Other Current Liabilities is MXN0 Mil. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' Other Current Liabilities compare to RZLT and EIKN?
Ginkgo Bioworks Holdings' Other Current Liabilities of MXN0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ginkgo Bioworks Holdings. Ginkgo Bioworks Holdings's current Other Current Liabilities is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ginkgo Bioworks Holdings (MEX:DNA) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN149.41, compared to a current price of MXN170.00 — trading 13.8% above its estimated fair value. The current Other Current Liabilities is MXN0 Mil. Ginkgo Bioworks Holdings' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (MEX:DNA), the current Other Current Liabilities is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ginkgo Bioworks Holdings (MEX:DNA) Overvalued in 2026?

Based on GuruFocus' analysis, Ginkgo Bioworks Holdings stock appears to be overvalued. The current stock price of MXN170.00 is trading 13.8% above its estimated GF Value™ of MXN149.41. GuruFocus considers Ginkgo Bioworks Holdings to be Modestly Undervalued.

Key valuation signals for MEX:DNA:

  • Other Current Liabilities: MXN0 Mil
  • GF Value™: MXN149.41 vs. price of MXN170.00 (13.8% above fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the MEX:DNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:USA
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
54GF Score

Get the complete analysis for MEX:DNA

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price
MXN149.41
GF Value